$0.98
4.13% day before yesterday
Nasdaq, May 30, 10:00 pm CET
ISIN
US7743741024
Symbol
RMTI

Rockwell Medical, Inc. Stock price

$0.98
-0.10 8.97% 1M
-1.26 56.11% 6M
-1.06 51.81% YTD
-0.79 44.46% 1Y
-0.41 29.27% 3Y
-22.01 95.72% 5Y
-125.19 99.22% 10Y
Nasdaq, Closing price Fri, May 30 2025
+0.04 4.13%
ISIN
US7743741024
Symbol
RMTI
Sector

Key metrics

Market capitalization $33.60m
Enterprise Value $26.28m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 12.17
EV/Sales (TTM) EV/Sales 0.27
P/S ratio (TTM) P/S ratio 0.34
P/B ratio (TTM) P/B ratio 1.07
Revenue growth (TTM) Revenue growth 12.83%
Revenue (TTM) Revenue $97.73m
EBIT (operating result TTM) EBIT $572.00k
Free Cash Flow (TTM) Free Cash Flow $2.16m
Cash position $17.33m
EPS (TTM) EPS $-0.01
P/E forward negative
P/S forward 0.49
EV/Sales forward 0.39
Short interest 0.63%
Show more

Is Rockwell Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Rockwell Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Rockwell Medical, Inc. forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Rockwell Medical, Inc. forecast:

Buy
100%

Financial data from Rockwell Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
98 98
13% 13%
100%
- Direct Costs 80 80
4% 4%
82%
17 17
90% 90%
18%
- Selling and Administrative Expenses 17 17
13% 13%
17%
- Research and Development Expense - -
-
-
2.75 2.75
158% 158%
3%
- Depreciation and Amortization 2.17 2.17
19% 19%
2%
EBIT (Operating Income) EBIT 0.57 0.57
109% 109%
1%
Net Profit -0.26 -0.26
97% 97%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Rockwell Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rockwell Medical, Inc. Stock News

Neutral
Seeking Alpha
20 days ago
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Heather Hunter - SVP, Chief Corporate Affairs Officer Mark Strobeck - President & CEO Jesse Neri - CFO Conference Call Participants Ram Selvaraju - H.C. Wainwright Jeremy Pearlman - Maxim Group Operator Good morning, and welcome to Rockwell Medical's First Quarter 2025 Results Con...
Neutral
Business Wire
20 days ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces financial and operational results for the three months ended March 31, 2025.
Neutral
Business Wire
about 2 months ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the first quarter ended March 31, 2025 on Monday, May 12, 2025.
More Rockwell Medical, Inc. News

Company Profile

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.

Head office United States
CEO Mark Strobeck
Employees 244
Founded 1995
Website www.rockwellmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today